Additionally, Ryan et al. conducted a 6-week crossover dietary intervention study with the MedDiet and observed a significant reduction in liver steatosis and improved insulin sensitivity in insulin-resistant patients with MASLD (40). This evidence concerns the gene INS and fatty liver disease.